Effect of Shenling Baizhu Powder on Tumor Markers and Immune Function in Postoperative Chemotherapy Patients with Colorectal Cancer

Key Points

• This investigation aims to analyze the effect of Shenling Baizhu Powder on tumor markers and immune function in patients undergoing postoperative chemotherapy for colorectal cancer.
• 86 postoperative colorectal cancer patients receiving chemotherapy were randomly divided into two groups: control (XELOX) and observation (XELOX + Shenling Baizhu Powder).
• Clinical efficacy, traditional Chinese medicine syndrome scores, tumor markers, quality of life, immune function, and adverse reactions were compared between groups.
• Assessments were conducted post-treatment to evaluate the outcomes.
• The clinical effective rate in the observation group was significantly higher than in the control group (P<0.05).
• Traditional Chinese medicine syndrome scores and tumor marker levels were lower in the observation group, with Karnofsky scores higher than those in the control group (P<0.05).
• CD4+, CD4+/CD8+ levels were higher and CD8+ levels were lower in the observation group compared to the control group (P<0.05); adverse reaction rates were also lower in the observation group (P<0.05).